Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional ...

It comes as companies work to build goodwill with Trump, who has emphasized reshoring manufacturing to the U.S. and reducing ...

Over the last few years, as Eli Lilly has revealed a series of manufacturing investments—each one seemingly more lavish than ...

The business of GLP-1s, it's mass adoption, compounded GLP-1s, compounding pharmacies, venture capital, and economic impact ...

“Mounjaro’s changed my life and it might have even saved my life,” Mark said. “I couldn’t walk across the car park in June ...

THE family of a man who died after taking Mounjaro want a probe into the weight-loss drug’s “potential to kill”. It comes after The Sun revealed 82 deaths have been linked to anti-fat and diabetes ...

David Ricks said drugs like Mounjaro and Zepbound are priced to reflect the costs involved, patent expiry, and the enormous ...

Viking Therapeutics (NASDAQ: VKTX) soared into the spotlight about a year ago when it delivered promising data on a drug ...

Pharmaceutical giant Eli Lilly is once again expanding the supply of its weight-loss drug Zepbound and cutting the cost for patients that don't have insurance.

Goldberg has been open about her own weight loss on The View. During a March 2024 episode of the show, she disclosed that she ...

Eli Lilly was second to the lucrative GLP-1 market for diabetes and obesity following its chief metabolic medicine rival Novo ...

New research finds older women achieve the best results with weight loss injections – thanks to consistent tracking and ...